Pharmacologic Class Information
|Pharmacologic Name||Decreased Vascular Permeability|
|Pharmacologic Concept||Physiologic Effects - [PE]|
|Pharmacologic Concept Description||This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.|
NDC Products with Decreased Vascular Permeability
The table contains 1 products whose active ingredient are classified under the same pharmacologic class Decreased Vascular Permeability [PE].
|NDC||Proprietary Name||Non-Proprietary Name||Dosage Form||Route Name||Company Name||Status|
|42227-081||Cinryze||Non-Proprietary Name: Human C1-esterase Inhibitor||Injection, Powder, Lyophilized, For Solution||Intravenous||Takeda Pharmaceuticals America, Inc.||ACTIVE|